IP Library Granted Patent US 7,816,461
Granted Patent B2
US 7,816,461 · App. 11/718,962 · Granted Oct 19, 2010

Block copolymers of polycarpolactone and poly (propylene funarate)

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,816,461
App. No.
11/718,962
Granted
Oct 19, 2010
Kind
B2
Abstract

Poly(propylene fumarate) is copolymerized with poly(caprolactone) diol to produce a block copolymer of poly(propylene fumarate) and poly(caprolactone). The biocompatible and bioresorbable block copolymer of poly(propylene fumarate) and poly(caprolactone) is useful in the fabrication of injectable and in-situ hardening scaffolds for tissue and/or skeletal reconstruction. The block copolymer can be crosslinked by redox or photo-initiation, with or without an additional crosslinker. Thus, the copolymer is both self-crosslinkable (without the use of any crosslinkers) and photocrosslinkable (in the presence of photons such as UV light).

Claims (39)

1. A block copolymer comprising:

caprolactone units; and

propylene fumarate units wherein the block copolymer has the following formula:

wherein n, m and p are integers.

2. The block copolymer of claim 1 wherein:

n is 1 to 16, m is 5 to 24, and p is 5 to 24.

3. The block copolymer of claim 1 wherein:

the block copolymer has a number average molecular weight of 5000 daltons or greater.

4. The copolymer of claim 1 wherein the copolymer is prepared by reacting (i) polycaprolactone diol and (ii) poly(propylene fumarate).

5. The copolymer of claim 4 wherein:

the polycaprolactone diol has molecular weight in the range of 500 to 10,000 daltons.

6. A crosslinkable, biodegradable material comprising:

the block copolymer of claim 1 wherein the propylene fumarate units comprise poly(propylene fumarate) and wherein the caprolactone units comprise poly(ε-caprolactone);

and

a free radical initiator or photoinitiator.

7. The material of claim 6 wherein:

the material includes a free radical initiator, and

the material is self-crosslinkable.

8. The material of claim 6 wherein:

the material includes a photoinitiator, and

the material is photocrosslinkable.

9. The material of claim 6 wherein:

the material is injectable.

10. The material of claim 6 wherein:

the material is a bone substitute.

11. The material of claim 6 wherein:

the material is a bone cement.

12. The material of claim 6 further comprising:

a porogen.

13. The material of claim 6 further comprising:

an accelerator.

14. The material of claim 6 wherein:

the material does not include a crosslinker.

15. The material of claim 6 further comprising:

particulate or fiber reinforcement materials.

16. The material of claim 15 wherein:

the reinforcement materials comprise hydroxyapatite.

17. The material of claim 6 wherein:

the copolymer is prepared by reacting (i) poly(caprolactone) diol and (ii) poly(propylene fumarate).

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 8, 2008
From: MAYO FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021497/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2008
From: WANG, SHANFENG; YASZEMSKI, MICHAEL; LU, LICHUN; CURRIER, BRADFORD L.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 020498/0695 →
Continuity (2)
Provisional Application 6062919800 · Nov 18, 2004
Related Publication 20080004368A1 · Jan 3, 2008